| Sep 3 |
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
|
| Aug 29 |
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
|
| Aug 28 |
Metagenomi to Participate in Upcoming Investor Conferences
|
| Aug 15 |
Metagenomi, Inc. GAAP EPS of -$0.29, revenue of $20M
|
| Aug 14 |
Metagenomi: Q2 Earnings Snapshot
|
| Aug 14 |
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
|
| Aug 12 |
Metagenomi, Inc. (MGX): This New Penny Stock Received a Positive Rating From Street Analysts
|
| Aug 8 |
With 33% stake, Metagenomi, Inc. (NASDAQ:MGX) seems to have captured institutional investors' interest
|
| Aug 5 |
IPO Roundup: zSpace, Actuate Therapeutics and more
|
| Aug 4 |
Wall Street Breakfast: The Week Ahead
|
